CN101191133B - Carrier for catching secretion sequence and its construction method and application thereof - Google Patents
Carrier for catching secretion sequence and its construction method and application thereof Download PDFInfo
- Publication number
- CN101191133B CN101191133B CN2006101344435A CN200610134443A CN101191133B CN 101191133 B CN101191133 B CN 101191133B CN 2006101344435 A CN2006101344435 A CN 2006101344435A CN 200610134443 A CN200610134443 A CN 200610134443A CN 101191133 B CN101191133 B CN 101191133B
- Authority
- CN
- China
- Prior art keywords
- carrier
- plasmid
- sequence
- agav
- secretion sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the molecular biology and genetic engineering field, in particular to a carrier for capturing secretion sequence and a constructive method and application of the carrier. The capturing carrier contains agar enzyme genes agaV excluded signal sequence, an exogenous gene insertion sites and filtered markings. The mature agar enzyme genes agaV is utilized to be taken as reportmolecules, and functional signal sequences and secretory protein genes can be quickly and highly efficiently filtered from Gram-positive bacteria and Gram-negative bacteria. The invention not only ca n filter the secretory protein genes from unknown genomes but also can verify presumptive secretory signals, detect functions of promoters and SD sequences, and extensively filter manual strong force signal peptides and so on. Moreover, operation of the invention is simple and only conventional connection, conversion and color filtration are needed; captured genes have no false positive and 100 percent of the captured genes have typical characteristics of the secretory protein genes, thereby the invention provides candidate vaccine antigens and medicine targets for prevention and cure of pathogenic microorganism diseases.
Description
Technical field
The present invention relates to molecular biology and genetically engineered field, specifically a kind of carrier of catching secretion sequence and construction process thereof and application.
Background technology
Protein one of the basic support that exists of relying for all life systems.In various cell proteins, secreted protein (comprising cytolemma guidance quality albumen and pericentral siphon chamber albumen) is an important class.These albumen contain the signal that can be discerned by the emiocytosis factor usually in its primary structure, Jing Dian I type secretory protein for example, especially the excretory albumen via the Sec approach, usually contain a signal peptide of being made up of 20-35 amino acid at its N end, the proteic formation of successfully striding film transportation and functional structure picture that this signal peptide draws for its rate has decisive role.Based on its particular structure and effect characteristics, secreted protein has important biomolecule function usually in prokaryotic organism, for example to the perception and the conduction of ambient signal, interact with host cell, population density induction etc., these unique functions make secreted protein Chang Zuowei medicine and vaccine target spot in the pathogenic micro-organism diseases prevention and treatment, thereby the screening of the systematicness of secretory protein is significant for the life mechanism of research bacterium, pathogenesis, disease control etc.
Agarase is a kind of natural glycoside hydrolase, how is produced by marine microorganism, and its effect substrate is an agar-agar, and 1,3 β-D-or 1,4 α-L-galacto-pyranose in can the cracking agar-agar connect.Though various in recent years novel product agarase bacterial strains constantly are found, agarase gene and proteic research also day by day deeply, yet it is few really to be successfully applied to the agarase of industry or scientific research field.The actual property application of agarase at present mainly is limited to reclaims DNA or other molecule from the agar-agar embedding medium, its potentiality is used and is comprised and be used to prepare the agar-agar oligosaccharide etc. of deriving, but the research that the agarase gene is used as a kind of biology tool does not appear in the newspapers as yet.
Agarase agaV is a conservative property I class secretory protein, have typical Sec-translocon dependent form secretory protein constitutional features and matrix folding ability of mind efficiently, and outer active the detection simply directly of its born of the same parents, yet, the report that utilizes agarase gene trap secretion signal is not arranged up to now in the world as yet.
Summary of the invention
The object of the invention is a kind of carrier and construction process and application of advantages of simplicity and high efficiency catching secretion protein gene sequence.
For achieving the above object, technical scheme of the present invention is: carrier is: have base sequence among the sequence table SEQ IDNo:2, contain the agarase gene agaV of the number of writing to sequence, foreign gene inserts site and selection markers.
Construction process:
1) design plasmid pBK:
A. be template with plasmid pACYC177,, use restriction enzyme BamHI and HincII double digestion behind the PCR product purification with the kanamycin gene primer that contains BamHI site and HincII site respectively, pcr amplification kanamycin gene;
Wherein: the PCR condition is: 94 ℃ of pre-sex change template DNAs of 60s, 94 ℃ of 40s then, 45 ℃ of 60s, 72 ℃ of 60s change 94 ℃ of 40s into after 5 circulations, 58 ℃ of 60s, 72 ℃ of 60s, after 25 circulations again at 72 ℃ of extension 10min;
B. plasmid pBR322 is cut with BamHI and ScaI enzyme, electrophoresis reclaims the 3471bp dna fragmentation, cut the PCR product of handling and be connected obtaining enzyme in this fragment and a step, connect liquid transformed into escherichia coli DH5 α, incubated overnight in containing kantlex LB substratum, filter out the transformant of anti-kantlex, from transformant, extract recombinant plasmid, be pBK;
2) design plasmid pUALS:
A. the operon of agaV is cloned into plasmid pUC19, constitute recombinant plasmid pBUA1, be template then with plasmid pBUA1, primer with containing BamHI site and XhoI site respectively carries out pcr amplification, obtains the PCR product of the agaV of the number of writing to sequence, with the PCR product purification, then be connected in room temperature, connect mixed solution transformed into escherichia coli DH5 α, on the LB solid medium that contains 100ug/ml Ap, 40ug/ml Xga1 and 24ug/ml IPTG, cultivate the white transformant of screening with carrier pBS-T;
Wherein: the PCR condition: 94 ℃ of pre-sex change template DNAs of 60s, 94 ℃ of 40s then, 46 ℃ of 60s, 72 ℃ of 60s change 94 ℃ of 40s into after 5 circulations, 59 ℃ of 60s, 72 ℃ of 60s, after 25 circulations again at 72 ℃ of extension 10min;
B. from the white transformant of picking, extract recombinant plasmid, be pUALS;
3) design secretion sequence capturing carrier:
A. the plasmid pBK that obtains in the step 1) is cut with restriction enzyme BamHI and BsaBI enzyme, obtain the 3.2kbDNA fragment; With step 2) in plasmid pUALS with restriction enzyme BamHI and SmaI double digestion, obtain the 1.3kb dna fragmentation, it is connected with preceding 3.2kb dna fragmentation, connects and containing the transformant that screens anti-kantlex on the LB solid medium of Kn after liquid is transformed into bacillus coli DH 5 alpha;
B. from the transformant of anti-kantlex, extract recombinant plasmid, be secretion sequence capturing carrier pBU.
Primer among the described step 1) a is KnF2 5 '-AT
GGATCCACGGTTGATGAGAGC-3 ', KnR3 5 '-GCC
GTCGACCAATTAACCAATTC-3 '.
Described step 2) primer among a is UAF5 5 '-AT
GGATCCGAAGACTGGCGAGAAATC-3 ' UAR3 5 '-CA
CTCGAGTTGTATAAATTTCAATCGC-3 '.
Described step 2) obtain the PCR product purification of agaV of the number of writing to sequence after, be connected 2-4 hour with carrier pBS-T in room temperature.
Described carrier can be caught secreted protein gene in the prokaryotic organism.
The present invention has following advantage:
1. applied widely.The present invention can be used for the screening of prokaryotic organism signal sequence, especially the still unknown microorganism of genome sequence.
2. functional diversity.The present invention not only can screen secreted protein gene from the unknown gene group, but also can be to the Function detection of checking, promotor and SD (ShineDalgarno) sequence of supposition (putative) secretion signal, the extensive screening of artificial strong signal peptide etc.
3. simple high efficiency.The present invention is simple to operate, only needs conventional connection, conversion and dithering; The gene non-false positive of being caught, 100% has typical secreted protein gene feature.
Description of drawings
Fig. 1 makes up the schema of catching secretion protein gene sequence carrier for the present invention.
Representative S.iniae (G26) the protein signal peptide prognostic chart that Fig. 2 the present invention filters out.
Representative V.harveyi (T4) the protein signal peptide prognostic chart that Fig. 3 the present invention filters out.
Embodiment
The invention will be further described below in conjunction with drawings and Examples.Embodiment is intended to the description of giving an example to the present invention, but not limits the invention in any form.
The present invention utilizes agaV structure gene as reporter gene, becomes a kind of secretion signal capturing carrier with the plasmid pBR322 plasmid construction of deriving; In this capturing carrier, foreign DNA can be inserted into the upstream of agaV gene via a BamHI site; Because disappearance signal sequence and promotor, agaV gene in this capturing carrier is beyond expression, if but contain a functional gene in the exogenous dna fragment that inserts in coding region fracture (truncated), and 5 ' coding region of this split gene and agaV gene are connected to form in-frame and merge, and the mode that the agaV gene just can fusion gene is expressed so; If the split gene that inserts contains secretory signal sequence, and this signal sequence can be discerned by colibacillary excretory system, the heterologous peptides of Rong Heing is tolerated by agaV simultaneously, do not influence the formation and the functionally active in its key structure territory, the form that the agaV after expressing so then can fusion rotein be transported to born of the same parents outer and have with wild-type similarly, can detected activity.The split gene sequence of being inserted can be known via the agaV upstream is checked order, use methods such as chromosome walking, molecular hybridization to clone at an easy rate subsequently and obtain complete secretory gene.Because the conservative property and the extensive existence of I class film guiding protein in prokaryotic organism of Sec excretory system, this capturing carrier can be applied to the screening of all prokaryotic organism (comprising Gram-positive and gram negative bacterium) secretion signal, and thus obtained secretory protein can be used for multiple purpose.
Involved in embodiments of the present invention experimental technique all adopts following method:
1. plasmid extraction, PCR product purification, corresponding reagent box (the Plasmid Mini Kit I that dna fragmentation reclaims from gel, the bacterial genomes DNA extraction is all used U.S. Omega Bio-Tek company, Cycle-pure Kit, Gel Extraction Kit, Bacterial DNA Kit)
2. plasmid, the conversion of DNA connection liquid enter intestinal bacteria and all use Hanaban method (Sambrook andRussell:Molecular Cloning:A Laboratory Mannual.Cold Spring HarborLaboratory Press 2001);
3. all restriction enzymes and ligase enzyme are all available from " Niu Yinglun Bioisystech Co., Ltd ", Beijing.
Embodiment 1
The building process (referring to Fig. 1) of secretion signal capturing carrier pBU
The structure of step 1) carrier pBK.
A. be template with plasmid pACYC177 (coming from " Niu Yinglun Bioisystech Co., Ltd ", Beijing), with following primer PCR kantlex (Kn) gene: KnF2 (5 '-AT
GGATCCACGGTTGATGAGAGC-3 ', the line base is the BamHI site), KnR3 (5 '-GCC
GTCGACCAATTAACCAATTC-3 ', the line base is the HincII site), the PCR condition is: 94 ℃ of pre-sex change template DNAs of 60s, 94 ℃ of 40s then, 45 ℃ of 60s, 72 ℃ of 60s change 94 ℃ of 40s into after 5 circulations, 58 ℃ of 60s, 72 ℃ of 60s, after 25 circulations again at 72 ℃ of extension 10min.The PCR product is used restriction enzyme BamHI and HincII double digestion after using Omega Cycle-pure test kit purifying, then with using Omega Cycle-pure test kit purifying.
B. with plasmid pBR322 (available from " Shanghai Sangon Biological Engineering Technology And Service Co., Ltd ", Shanghai) cut with BamHI and ScaI enzyme, electrophoresis reclaims the 3471bp dna fragmentation, this fragment and preceding BamHI/HincII enzyme are cut the PCR product of handling to be connected, connect liquid Hanahan method transformed into escherichia coli DH5 α, on the Luria-Bertani that contains Kn (50ug/ml) (LB) culture medium flat plate, screen transformant, extract the plasmid of transformant with Omega Plasmid Mini Kit, be plasmid pBK, this plasmid after restriction enzyme BamHI and SmaI enzyme are cut in 0.8% sepharose electrophoresis, electrophoresis result shows that it is two bands that enzyme is cut product, article one, size is about 550bp, another is 4kb, illustrates that this plasmid is correct recombinant plasmid.
Described LB moiety is by weight percentage: 1.0% peptone, 0.5% yeast powder, 1.0% sodium-chlor.
Step 2) structure of carrier pUALS.
A. the operon of the agarase agaV in the Vibrio anguillarum being cloned into plasmid pUC19 (commercial), constituting recombinant plasmid pBUA1, is template with plasmid pBUA1 then, with primer UAF5 (5 '-AT
GGATCCGAAGACTGGCGAGAAATC-3 ', the line base is the BamHI site) and UAR3 (5 '-CA
CTCGAGTTGTATAAATTTCAATCGC-3 ', the line base is the XhoI site) carry out pcr amplification, obtain the PCR product of the agaV of the number of writing to sequence.The PCR product with Omega Cycle-pure test kit purifying after with PCR cloning vector pBS-T (" day root biochemical technology company limited ", Beijing) connect 2 hours in room temperature, connect mixed solution with Hanahan method transformed into escherichia coli DH5 α after cultivation 18 hours on the LB solid medium that contains 100ug/ml Ap, 40ug/ml Xga1 and 24ug/ml IPTG, filter out white transformant.
The PCR condition: 94 ℃ of pre-sex change template DNAs of 60s, 94 ℃ of 40s then, 46 ℃ of 60s, 72 ℃ of 60s change 94 ℃ of 40s into after 5 circulations, 59 ℃ of 60s, 72 ℃ of 60s, after 25 circulations again at 72 ℃ of extension 10min.
Wherein agarase agaV sequence table is as follows:
atgaaatcca?taattaaaac?tctgacattg?ctaccaatat?ttttaactag?cacgacgtta
atggctgaag?actggcgaga?aatccccatt?ccagcaccgt?tagaagatgg?gcagagctgg
gagttacaag?aggcatactc?cgattcgttt?aattatacgg?gtaagggcga?ctctttccgt
agtaagtgga?atgataccta?ctttcacggt?tggacaggac?ctggtttaac?ctattggcaa
agtgatgagt?catgggtaga?tgatggcaac?ttgataatca?gtgcctctcg?tcgtcaggga
acagagatgg?tgaatgcggg?cgttgtgacg?tctaagacaa?aggtgaaata?tcctattttt
ctagaggcca?atataaaggt?gagtggctta?gagctatcat?caaatttttg?gcttcttagt
gaaaatgatc?aacgagaaat?cgatgtattg?gaagtgtatg?gtggcgctga?agacgaatgg
tttgccaaaa?atatgtcaac?aaacttccat?gtatttttcc?gcaatgaaga?caactcaatt
cgtagcgatt?tcaacgatca?gacccacaat?gagccgcaat?ggggtactta?ttggcgtgat
gggttccatc?gctttgcggt?atattggaaa?agcccaactg?aagtgacttt?ttatatcaat
ggcatagaga?caccgaaagg?ttcttgggaa?gacgtcgtaa?tgaaagataa?agattacacg
ggagccatcc?tagataaatc?aacctacaac?atggatcaag?agatgttcat?tattattgat
actgaagacc?attcgtggcg?ttctgaggct?ggaataatcg?caaaagatga?agacctagct
gatgatagta?agaacaaaat?gtatgtggat?tggatacgtg?tttataagcc?agttggcgga
gatgacaatg?gtaatgtgac?cgtaccgtca?gggtatacaa?acacacaatt?tgtgcatagt
gacttgtgtt?tggatgtcaa?agatggagcg?acttggaacg?gcagtactta?tcagcaatgg
gtgtgtaata?cgggcaacct?gaaccaacga?tttgggtttg?aagaagtcgc?gacgggagag
tatttaatta?aatccaaacg?tagtcagctg?tgcttagagc?tcaagcccgg?tagtaatcaa
tggcaggacg?gtgcgatcat?tcagcaatat?gtgtgtaatt?cagctgaaga?gaatcaacgt
tggacgctat?ttgataaagg?cagccagacg?tttgagattc?gaagcaaggc?aacaggtaag
tgtttagagc?ttgctgacaa?tcagggaagc?aacggcggga?cagtgcagca?atggtcatgt
gatggtggta?ataaccagcg?attgaaattt?atacaataa
B. adopt Omega Plasmid Mini Kit to extract plasmid in the white transformant, be plasmid pUALS, this plasmid with restriction enzyme BamHI/XhoI double digestion after in 0.8% sepharose electrophoresis, electrophoresis result shows that it is two bands that enzyme is cut product, article one, size is about 1.3kb (agaV inserts fragment), another is 3kb (a pBS-T carrier), illustrates that this plasmid is correct recombinant plasmid.
The structure of step 3) secretion sequence capturing carrier pBU.
The plasmid pBK of step 1) is cut with restriction enzyme BamH I and BsaBI enzyme, and electrophoresis in 0.8% sepharose reclaims the 3.2kb dna fragmentation; With step 2) plasmid pUALS cut with restriction enzyme BamHI and SmaI enzyme, electrophoresis in 0.8% sepharose, reclaim the 1.3kb dna fragmentation, it is connected with 3.2kb pBK/BamHI/BsaBI fragment, connects and on the LB solid medium that contains Kn (50ug/ml), screen transformant after liquid is transformed into bacillus coli DH 5 alpha with the Hanahan method.2 transformants of picking, extract plasmid with Omega Plasmid Mini Kit, be plasmid pBU (referring to sequence table 2), this plasmid with restriction enzyme BamHI/XhoI double digestion after in 0.8% sepharose electrophoresis, electrophoresis result shows that it is two bands that enzyme is cut product, article one, size is about 1.3kb, and another is 3.2kb, illustrates that this plasmid is correct recombinant plasmid, pBU total length: 4577bp, be double-stranded DNA, pBU characteristics (main element): agaV:1-1302, Kn
r: 4577-3480, Origin:2773-2185.
Embodiment 2
Adopt capturing carrier pBU to screen secretion sequence and secreted protein gene (G26) from gram-positive microorganism Streptococcus iniae (Streptococcus iniae).(its composition is: peptone 1.7% at 5ml TSAYE substratum, polypeptone 0.3%, yeast extract 0.6%, NaCl 1.5%, K2HPO40.327%, glucose 0.25%, agar 1.5%) middle incubated overnight S.iniae bacterial strain G26, extract genomic dna with Omega Bacterial DNA test kit, with the 5ug genomic dna partially digested back of restriction enzyme Sau3AI electrophoresis in 0.8% agar gel, reclaim the 4-6kb dna fragmentation with Omega GelExtraction test kit, the DNA that 400ng is reclaimed and 200ngBamHI linearizing and the plasmid pBU that handled through calf alkaline phosphatase (CIP) are connected, and the connection mixed solution screens transformant after with Hahahan method transformed into escherichia coli DH5 α on the LB nutrient agar that contains Kn (50ug/ml).From transforming on the flat board transformant of 6 peripheral substratum depressions of picking at random, with transformant incubated overnight in the LB substratum that contains Kn (50ug/ml) of picking, extract plasmid and its contained insertion dna fragmentation is checked order with primer UAR6 (5 '-CTCATCACTTTGCCAATAGG-3 ') with OmegaPlasmid Mini Kit test kit.Sequencing result finds all to contain in all 6 recombinant plasmids the fracture functional gene of a tool signal peptide sequence behind bioinformatic analysis as follows, wherein: signal peptide is made up of about 15-35 amino acid usually, be positioned at the N end or the C end of secretory protein, it is formed amino acid and mostly is hydrophobicity and nonpolar amino acid, but near the several amino acid its N end is generally basic aminoacids, and line amino acid is signal peptide characteristic strong basicity amino acid in the bracket.
BUG1
FPVAVVNQDKGASLDNKSINVGNEMVDTLSKNKDLDFHFVSEKTAQEK
LDAGKYYMIITFPDNFSSKVASVM
BUG2
DLKPLAETASLSFIRKSAHSAADIARKNDLYTSVMLAQATLESQNGQSQLSQKPY
YNFFGVKGDYKGKSAVLPTLEDDGQGNLYTVDAKFRSYGKMINSFKD
YATVLSDPLYENTHKAKTKHYQEATATLTGRYATDTSYHVKLNNLIET
YRLYYFD
It is as follows that its coded product of fracture functional gene of catching is all secreted protein: wherein the capitalization part is secretory signal sequence in this sequence
G26
BUG1:
ATGTTTAAAGAAACAAGGACATTATTAAAAAGCCCAAACCTATGGGTAACAATCATAGGGATAG
CTTTGGTTCCTGCACTATATTGCCTGGTTTTCCTCAGTTCTATGTGGAATCCTTATGCCcacttcaaccaa
tttccagttgccgttgtcaatcaagataagggtgctagcttagataataaatccatcaacgtcggaaatgagatggtggacacactgtcaaaaaataaggactt
ggattttcatttcgtttctgaaaaaacagctcaagaaaaacttgatgctgggaaatactatatgattatcactttcccagataatttttcaagtaaagttgcctctgtg
atgac
BUG2:
ATGGGCAGAAAAAAAAGAAAAAGAAGTTATCAGCTAAAAAAAACAAGTTCAAAAGGGTTTAA
GTTAACTGTTTTAAGTTTTGTTCTTTTGACATTACTAGTTTCAGTATGGTCTTTAAAAAAAGCTagg
caagatttgaaacctttagctgaaacagcctctttatcatttataagaaaaagtgcacattcagcggcagatatagcaagaaaaaatgatctatatacgtcagtg
atgcttgcgcaagcaactctagagtcgcaaaatggccaatcccaattgagtcaaaaaccttattataatttctttggggtgaaaggagattacaaaggaaaatc
tgctgttttacccactctagaagatgatggtcaagggaatctttatacagttgatgcaaagtttagatcttacggaaaaatgattaattcttttaaagactatgcaac
tgtattatcagaccctttgtatgaaaatactcataaagctaaaacaaaacactatcaagaagcaacagcaactttaacgggtcgttatgcaacagacacgtctta
tcatgtcaaattaaataatcttattgagacttataggctttattattttgacta
Can get the sequence (referring to Fig. 2) that secretion sequence that carrier that the present invention makes up catches is all the coding secreted protein by detecting.
Embodiment 3
(its composition is: peptone 1.7% at the 5mlTSAYE substratum from Gram-negative bacteria Vibrio harveyi V.harveyi (T4) to adopt capturing carrier pBU, polypeptone 0.3%, yeast extract0.6%, NaCl 1.5%, K2HPO4 0.327%, glucose 0.25%, agar 1.5%) middle incubated overnight V.harveyi bacterial strain T4, extract genomic dna with Omega Bacterial DNA test kit, with the 5ug genomic dna partially digested back of restriction enzyme Sau3AI electrophoresis in 0.8% agar gel, reclaim the 4-6kb dna fragmentation with Omega Gel Extraction test kit, the DNA that 400ng is reclaimed and 200ng BamHI linearizing and the plasmid pBU that handled through calf alkaline phosphatase (CIP) are connected, and the connection mixed solution screens transformant after with Hanahan method transformed into escherichia coli DH5 α on the LB nutrient agar that contains Kn (50ug/ml).From transforming on the flat board transformant of 7 peripheral substratum depressions of picking at random, with transformant incubated overnight in the LB substratum that contains Kn (50ug/ml) of picking, extract plasmid and its contained insertion dna fragmentation is checked order with primer UAR6 (5 '-CTCATCACTTTGCCAATAGG-3 ') with Omega Plasmid Mini Kit test kit.Sequencing result finds all to contain in all 7 recombinant plasmids the fracture functional gene of a tool signal peptide sequence behind bioinformatic analysis as follows, wherein: signal peptide is made up of about 15-35 amino acid usually, be positioned at the N end or the C end of secretory protein, it is formed amino acid and mostly is hydrophobicity and nonpolar amino acid, but near the several amino acid its N end is generally basic aminoacids, and line amino acid is signal peptide characteristic strong basicity amino acid in the bracket.
BUS1
VNEKNGTVSLLDIKSGKPQKLFNVPDVNTSGQAGLLDVALTPNADKQ
NPQLFFTYSKRTSK
BUS2
SNYFNYQIRNDGFEITHGRDGFIGASTEFNNQSIRVGLDTNQDLGVKY
LINTSTGAKASLDVGLLSAFFRYQGQSANAHSDNAQN
It is as follows that its coded product of fracture functional gene of catching is all secreted protein: wherein the capitalization part is screening secretion sequence and secreted protein gene in the secretory signal sequence in this sequence.
T4
BUS1:
ATGAGAACGATTGCTGCTGCCCTACTCGCTTGTTTATCCTTTTCTGCCAACGCTgccg
aataccgcgctaacgaagtggcgaatggatttcagatcccttggggaatcgagttcttagacaaccaacgcgttatcgtcaatgaaaag
aacggtacggtttcgctgctggatatcaaatcaggcaaacctcaaaagctgtttaacgtccccgatgtgaacaccagtggacaagcgg
gcttattggatgttgcgctcacaccgaatgccgataagcaaaacccgcaactcttctttacctacagcaagcgtacgagcaaagg
BUS2-Blue:
ATGAAAAAAATATTATTGTTTTCGATACTTGCTTACTCAACACTTAGTTACGCAagaatc
cccaattctctgcaagaccagaatattacaattactgtaaagtatgataaggaaactcaagaattctatgatttgagtgctactggatccaat
tattttaactatcagataagaaacgatggttttgaaataacacatggtcgagatgggttcataggagcgagtacagagtttaataaccaatc
tataagggttgggctagatacgaatcaagacctaggtgtaaagtacttaattaacacgtcgacaggagcaaaagcatcgttggatgttgg
tcttttaagtgctttctttaggtatcaaggacagtcagctaatgctcacagcgacaacgcacagaatt
Can get the sequence (referring to Fig. 3) that secretion sequence that carrier that the present invention makes up catches is all the coding secreted protein by detecting.
Embodiment 2 and embodiment 3 results show that pBU can be used as a kind of broad spectrum (general) screening implement, screening function secretion sequence and secreted protein gene from Gram-positive and Gram-negative bacteria fast and efficiently.
The embodiment of the invention is intended to the description of giving an example to the present invention, but not limits the invention in any form.
(1) information of SEQ ID No:2 (referring to sequence table)
(a) sequence signature
* length: 4577 base pairs
* type: nucleic acid
* chain: two strands
* topological framework: ring-type
(b) molecule type: DNA
(c) suppose: not
(d) antisense: not
(e) initial source: synthetic
Sequence table
SEQUENCE?LISTING
<110〉Institute of Oceanology of the Chinese Academy of Sciences
<120〉a kind of carrier of catching secretion sequence and construction process thereof and application
<130>
<160>2
<170>PatentIn?version?3.1
<210>1
<211>1359
<212>DNA
<213>Vibrio?sp.
<220>
<221>gene
<222>(1)..(1359)
<223>
<400>1
atgaaatcca?taattaaaac?tctgacattg?ctaccaatat?ttttaactag?cacgacgtta 60
atggctgaag?actggcgaga?aatccccatt?ccagcaccgt?tagaagatgg?gcagagctgg 120
gagttacaag?aggcatactc?cgattcgttt?aattatacgg?gtaagggcga?ctctttccgt 180
agtaagtgga?atgataccta?ctttcacggt?tggacaggac?ctggtttaac?ctattggcaa 240
agtgatgagt?catgggtaga?tgatggcaac?ttgataatca?gtgcctctcg?tcgtcaggga 300
acagagatgg?tgaatgcggg?cgttgtgacg?tctaagacaa?aggtgaaata?tcctattttt 360
ctagaggcca?atataaaggt?gagtggctta?gagctatcat?caaatttttg?gcttcttagt 420
gaaaatgatc?aacgagaaat?cgatgtattg?gaagtgtatg?gtggcgctga?agacgaatgg 480
tttgccaaaa?atatgtcaac?aaacttccat?gtatttttcc?gcaatgaaga?caactcaatt 540
cgtagcgatt?tcaacgatca?gacccacaat?gagccgcaat?ggggtactta?ttggcgtgat 600
gggttccatc?gctttgcggt?atattggaaa?agcccaactg?aagtgacttt?ttatatcaat 660
ggcatagaga?caccgaaagg?ttcttgggaa?gacgtcgtaa?tgaaagataa?agattacacg 720
ggagccatcc?tagataaatc?aacctacaac?atggatcaag?agatgttcat?tattattgat 780
actgaagacc?attcgtggcg?ttctgaggct?ggaataatcg?caaaagatga?agacctagct 840
gatgatagta?agaacaaaat?gtatgtggat?tggatacgtg?tttataagcc?agttggcgga 900
gatgacaatg?gtaatgtgac?cgtaccgtca?gggtatacaa?acacacaatt?tgtgcatagt 960
gacttgtgtt?tggatgtcaa?agatggagcg?acttggaacg?gcagtactta?tcagcaatgg 1020
gtgtgtaata?cgggcaacct?gaaccaacga?tttgggtttg?aagaagtcgc?gacgggagag 1080
tatttaatta?aatccaaacg?tagtcagctg?tgcttagagc?tcaagcccgg?tagtaatcaa 1140
tggcaggacg?gtgcgatcat?tcagcaatat?gtgtgtaatt?cagctgaaga?gaatcaacgt 1200
tggacgctat?ttgataaagg?cagccagacg?tttgagattc?gaagcaaggc?aacaggtaag 1260
tgtttagagc?ttgctgacaa?tcagggaagc?aacggcggga?cagtgcagca?atggtcatgt 1320
gatggtggta?ataaccagcg?attgaaattt?atacaataa 1359
<210>2
<211>4577
<212>DNA
<213〉synthetic
<220>
<221>gene
<222>(1)..(4577)
<223>
<400>2
ggatccgaag?actggcgaga?aatccccatt?ccagcaccgt?tagaagatgg?gcagagctgg 60
gagttacaag?aggcatactc?cgattcgttt?aattatacgg?gtaagggcga?ctctttccgt 120
agtaagtgga?atgataccta?ctttcacggt?tggacaggac?ctggtttaac?ctattggcaa 180
agtgatgagt?catgggtaga?tgatggcaac?ttgataatca?gtgcctctcg?tcgtcaggga 240
acagagatgg?tgaatgcggg?cgttgtgacg?tctaagacaa?aggtgaaata?tcctattttt 300
ctagaggcca?atataaaggt?gagtggctta?gagctatcat?caaatttttg?gcttcttagt 360
gaaaatgatc?aacgagaaat?cgatgtattg?gaagtgtatg?gtggcgctga?agacgaatgg 420
tttgccaaaa?atatgtcaac?aaacttccat?gtatttttcc?gcaatgaaga?caactcaatt 480
cgtagcgatt?tcaacgatca?gacccacaat?gagccgcaat?ggggtactta?ttggcgtgat 540
gggttccatc?gctttgcggt?atattggaaa?agcccaactg?aagtgacttt?ttatatcaat 600
ggcatagaga?caccgaaagg?ttcttgggaa?gacgtcgtaa?tgaaagataa?agattacacg 660
ggagccatcc?tagataaatc?aacctacaac?atggatcaag?agatgttcat?tattattgat 720
actgaagacc?attcgtggcg?ttctgaggct?ggaataatcg?caaaagatga?agacctagct 780
gatgatagta?agaacaaaat?gtatgtggat?tggatacgtg?tttataagcc?agttggcgga 840
gatgacaatg?gtaatgtgac?cgtaccgtca?gggtatacaa?acacacaatt?tgtgcatagt 900
gacttgtgtt?tggatgtcaa?agatggagcg?acttggaacg?gcagtactta?tcagcaatgg 960
gtgtgtaata?cgggcaacct?gaaccaacga?tttgggtttg?aagaagtcgc?gacgggagag 1020
tatttaatta?aatccaaacg?tagtcagctg?tgcttagagc?tcaagcccgg?tagtaatcaa 1080
tggcaggacg?gtgcgatcat?tcagcaatat?gtgtgtaatt?cagctgaaga?gaatcaacgt 1140
tggacgctat?ttgataaagg?cagccagacg?tttgagattc?gaagcaaggc?aacaggtaag 1200
tgtttagagc?ttgctgacaa?tcagggaagc?aacggcggga?cagtgcagca?atggtcatgt 1260
gatggtggta?ataaccagcg?attgaaattt?atacaactcg?agtgaatcga?attcctgcag 1320
cccgcatcgc?aggatgctgc?tggctaccct?gtggaacacc?tacatctgta?ttaacgaagc 1380
gctggcattg?accctgagtg?atttttctct?ggtcccgccg?catccatacc?gccagttgtt 1440
taccctcaca?acgttccagt?aaccgggcat?gttcatcatc?agtaacccgt?atcgtgagca 1500
tcctctctcg?tttcatcggt?atcattaccc?ccatgaacag?aaatccccct?tacacggagg 1560
catcagtgac?caaacaggaa?aaaaccgccc?ttaacatggc?ccgctttatc?agaagccaga 1620
cattaacgct?tctggagaaa?ctcaacgagc?tggacgcgga?tgaacaggca?gacatctgtg 1680
aatcgcttca?cgaccacgct?gatgagcttt?accgcagctg?cctcgcgcgt?ttcggtgatg 1740
acggtgaaaa?cctctgacac?atgcagctcc?cggagacggt?cacagcttgt?ctgtaagcgg 1800
atgccgggag?cagacaagcc?cgtcagggcg?cgtcagcggg?tgttggcggg?tgtcggggcg 1860
cagccatgac?ccagtcacgt?agcgatagcg?gagtgtatac?tggcttaact?atgcggcatc 1920
agagcagatt?gtactgagag?tgcaccatat?gcggtgtgaa?ataccgcaca?gatgcgtaag 1980
gagaaaatac?cgcatcaggc?gctcttccgc?ttcctcgctc?actgactcgc?tgcgctcggt 2040
cgttcggctg?cggcgagcgg?tatcagctca?ctcaaaggcg?gtaatacggt?tatccacaga 2100
atcaggggat?aacgcaggaa?agaacatgtg?agcaaaaggc?cagcaaaagg?ccaggaaccg 2160
taaaaaggcc?gcgttgctgg?cgtttttcca?taggctccgc?ccccctgacg?agcatcacaa 2220
aaatcgacgc?tcaagtcaga?ggtggcgaaa?cccgacagga?ctataaagat?accaggcgtt 2280
tccccctgga?agctccctcg?tgcgctctcc?tgttccgacc?ctgccgctta?ccggatacct 2340
gtccgccttt?ctcccttcgg?gaagcgtggc?gctttctcat?agctcacgct?gtaggtatct 2400
cagttcggtg?taggtcgttc?gctccaagct?gggctgtgtg?cacgaacccc?ccgttcagcc 2460
cgaccgctgc?gccttatccg?gtaactatcg?tcttgagtcc?aacccggtaa?gacacgactt 2520
atcgccactg?gcagcagcca?ctggtaacag?gattagcaga?gcgaggtatg?taggcggtgc 2580
tacagagttc?ttgaagtggt?ggcctaacta?cggctacact?agaaggacag?tatttggtat 2640
ctgcgctctg?ctgaagccag?ttaccttcgg?aaaaagagtt?ggtagctctt?gatccggcaa 2700
acaaaccacc?gctggtagcg?gtggtttttt?tgtttgcaag?cagcagatta?cgcgcagaaa 2760
aaaaggatct?caagaagatc?ctttgatctt?ttctacgggg?tctgacgctc?agtggaacga 2820
aaactcacgt?taagggattt?tggtcatgag?attatcaaaa?aggatcttca?cctagatcct 2880
tttaaattaa?aaatgaagtt?ttaaatcaat?ctaaagtata?tatgagtaaa?cttggtctga 2940
cagttaccaa?tgcttaatca?gtgaggcacc?tatctcagcg?atctgtctat?ttcgttcatc 3000
catagttgcc?tgactccccg?tcgtgtagat?aactacgata?cgggagggct?taccatctgg 3060
ccccagtgct?gcaatgatac?cgcgagaccc?acgctcaccg?gctccagatt?tatcagcaat 3120
aaaccagcca?gccggaaggg?ccgagcgcag?aagtggtcct?gcaactttat?ccgcctccat 3180
ccagtctatt?aattgttgcc?gggaagctag?agtaagtagt?tcgccagtta?atagtttgcg 3240
caacgttgtt?gccattgctg?caggcatcgt?ggtgtcacgc?tcgtcgtttg?gtatggcttc 3300
attcagctcc?ggttcccaac?gatcaaggcg?agttacatga?tcccccatgt?tgtgcaaaaa 3360
agcggttagc?tccttcggtc?ctccgatcgt?tgtcagaagt?aagttggccg?cagtgttatc 3420
actcatggtt?atggcagcac?tgcataattc?tcttactgtc?atgccatccg?taagatgctt 3480
ttctgtgact?ggtgagtttg?gttaattggt?taagactaat?ctttttgagt?agctcgtagt 3540
ttactttgac?gttaaataag?tatagtccta?atagttatgg?tataaaaact?ttttcggcaa 3600
agacattact?tcctcttttg?agtggctccg?tcaaggtatc?ctaccgttct?aggaccatag 3660
ccagacgcta?aggctgagca?ggttgtagtt?atgttggata?attaaagggg?agcagttttt 3720
attccaatag?ttcactcttt?agtggtactc?actgctgact?taggccactc?ttaccgtttt 3780
cgaatacgta?aagaaaggtc?tgaacaagtt?gtccggtcgg?taatgcgagc?agtagtttta 3840
gtgagcgtag?ttggtttggc?aataagtaag?cactaacgcg?gactcgctct?gctttatgcg 3900
ctagcgacaa?ttttcctgtt?aatgtttgtc?cttagcttac?gttggccgcg?tccttgtgac 3960
ggtcgcgtag?ttgttataaa?agtggactta?gtcctataag?aagattatgg?accttacgac 4020
aaaagggccc?ctagcgtcac?cactcattgg?tacgtagtag?tcctcatgcc?tattttacga 4080
actaccagcc?ttctccgtat?ttaaggcagt?cggtcaaatc?agactggtag?agtagacatt 4140
gtagtaaccg?ttgcgatgga?aacggtacaa?agtctttgtt?gagaccgcgt?agcccgaagg 4200
gtatgttagc?tatctaacag?cgtggactaa?cgggctgtaa?tagcgctcgg?gtaaatatgg 4260
gtatatttag?tcgtaggtac?aaccttaaat?tagcgccgga?gctcgttctg?caaagggcaa 4320
cttataccga?gtattgtggg?gaacataatg?acaaatacat?tcgtctgtca?aaataacaag 4380
tactactata?taaaaataga?acacgttaca?ttgtagtctc?taaaactctg?tgttgcaccg 4440
aaacaactta?tttagcttga?aaacgactca?acttcctagt?ctagtgcgta?gaagggctgt 4500
tgcgtctggc?aaggcaccgt?ttcgttttca?agttttagtg?gttgaccagg?tggatgttgt 4560
ttcgagagta?gttggca 4577
Claims (6)
1. the carrier of a catching secretion sequence, it is characterized in that: the carrier of catching secretion sequence is a base sequence among the sequence table SEQ ID No:2, and it contains the agarase gene agaV of the number of writing to sequence, and foreign gene inserts site and selection markers.
2. construction process by the described secretion sequence capturing carrier of claim 1 is characterized in that:
1) design plasmid pBK:
A. be template with plasmid pACYC177,, use restriction enzyme BamHI and HincII double digestion behind the PCR product purification with the kanamycin gene primer that contains BamHI site and HincII site respectively, pcr amplification kanamycin gene;
Wherein: the PCR condition is: 94 ℃ of pre-sex change template DNAs of 60s, 94 ℃ of 40s then, 45 ℃ of 60s, 72 ℃ of 60s change 94 ℃ of 40s into after 5 circulations, 58 ℃ of 60s, 72 ℃ of 60s, after 25 circulations again at 72 ℃ of extension 10min;
B. plasmid pBR322 is cut with BamHI and ScaI enzyme, electrophoresis reclaims the 3471bpDNA fragment, cut the PCR product of handling and be connected obtaining enzyme in this fragment and a step, connect liquid transformed into escherichia coli DH5 α, incubated overnight in containing kantlex LB substratum, filter out the transformant of anti-kantlex, from transformant, extract recombinant plasmid, be pBK;
2) design plasmid pUALS:
A. the operon of agaV is cloned into plasmid pUC19, constitute recombinant plasmid pBUA1, be template then with plasmid pBUA1, primer with containing BamHI site and XhoI site respectively carries out pcr amplification, obtains the PCR product of the agaV of the number of writing to sequence, with the PCR product purification, then be connected in room temperature, connect mixed solution transformed into escherichia coli DH5 α, on the LB solid medium that contains 100ug/ml Ap, 40ug/ml Xgal and 24ug/ml IPTG, cultivate the white transformant of screening with carrier pBS-T;
Wherein: the PCR condition: 94 ℃ of pre-sex change template DNAs of 60s, 94 ℃ of 40s then, 46 ℃ of 60s, 72 ℃ of 60s change 94 ℃ of 40s into after 5 circulations, 59 ℃ of 60s, 72 ℃ of 60s, after 25 circulations again at 72 ℃ of extension 10min;
B. from the white transformant of picking, extract recombinant plasmid, be pUALS;
3) design secretion sequence capturing carrier:
A. the plasmid pBK that obtains in the step 1) is cut with restriction enzyme BamHI and BsaBI enzyme, obtain the 3.2kbDNA fragment; With step 2) in plasmid pUALS with restriction enzyme BamHI and Sma I double digestion, obtain the 1.3kb dna fragmentation, it is connected with preceding 3.2kb dna fragmentation, connects and containing the transformant that screens anti-kantlex on the LB solid medium of Kn after liquid is transformed into bacillus coli DH 5 alpha;
B. from the transformant of anti-kantlex, extract recombinant plasmid, be secretion sequence capturing carrier pBU.
3. by the described secretion sequence capturing carrier of claim 2 construction process, it is characterized in that: the primer among the described step 1) a is KnF25 '-AT
GGATCCACGGTTGATGAGAGC-3 ', KnR35 '-GCC
GTCGACCAATTAACCAATTC-3 '.
4. by the described secretion sequence capturing carrier of claim 2 construction process, it is characterized in that: described step 2) primer among a is UAF55 '-AT
GGATCCGAAGACTGGCGAGAAATC-3 ' UAR35 '-CA
CTCGAGTTGTATAAATTTCAATCGC-3 '.
5. by the described secretion sequence capturing carrier of claim 2 construction process, it is characterized in that: after described step 2) obtaining the PCR product purification of agaV of the number of writing to sequence, be connected 2-4 hour in room temperature with carrier pBS-T.
6. application by the described secretion sequence capturing carrier of claim 1, it is characterized in that: described carrier can be caught secreted protein gene in the prokaryotic organism.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101344435A CN101191133B (en) | 2006-12-01 | 2006-12-01 | Carrier for catching secretion sequence and its construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101344435A CN101191133B (en) | 2006-12-01 | 2006-12-01 | Carrier for catching secretion sequence and its construction method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101191133A CN101191133A (en) | 2008-06-04 |
CN101191133B true CN101191133B (en) | 2010-04-07 |
Family
ID=39486334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101344435A Expired - Fee Related CN101191133B (en) | 2006-12-01 | 2006-12-01 | Carrier for catching secretion sequence and its construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101191133B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108359689B (en) * | 2018-01-19 | 2021-03-23 | 华中农业大学 | Method for identifying signal peptide with secretion function by using disease-resistant gene to identify nontoxic effector protein |
CN109593744B (en) * | 2019-01-31 | 2021-10-29 | 福州大学 | Agarase and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1460716A (en) * | 2003-06-04 | 2003-12-10 | 中国海洋大学 | Beta-agaropectinase gene aga, its preparation method and application |
-
2006
- 2006-12-01 CN CN2006101344435A patent/CN101191133B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1460716A (en) * | 2003-06-04 | 2003-12-10 | 中国海洋大学 | Beta-agaropectinase gene aga, its preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
CN101191133A (en) | 2008-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105368732B (en) | One plant of an industrial strain of S.cerevisiae strain for producing xylitol and construction method | |
US5286636A (en) | DNA cloning vectors with in vivo excisable plasmids | |
CN101302520B (en) | Transgenic rice TT51-1 transformation event foreign vector integration site complete sequence and use thereof | |
CN104962576B (en) | A kind of flavobacterium columnare gene orientation knocks out plasmid and application | |
CN101838663A (en) | Colibacillus-corynebacterium shuttle constitutive expression carrier and construction method thereof | |
CN113862166B (en) | Saccharomyces cerevisiae for producing naringenin | |
CN101191133B (en) | Carrier for catching secretion sequence and its construction method and application thereof | |
CN112266914B (en) | Strong constitutive promoter of bumblebee candida and application thereof | |
CN109234318B (en) | Method for improving monascus extracellular pigment | |
CN112813038A (en) | PRRS virus for expressing ASFV structural envelope protein and construction method and application thereof | |
CN107267538B (en) | A kind of construction method of plant plastid expression vector and application | |
CN114107369A (en) | Preparation method and application of MYC label fusion expression vector | |
CN110452893B (en) | Construction and application of high-fidelity CRISPR/AsCpf1 mutant | |
CN113913447B (en) | SARS-CoV-2 full-length cDNA clone single copy plasmid and its construction method | |
CN113151276A (en) | Zebra fish with IL-4 gene deletion | |
CN113755442B (en) | Cell strain for measuring pharmaceutical activity and preparation method and application thereof | |
CN111378684B (en) | Application of thermally-induced gene editing system CRISPR-Cas12b in upland cotton | |
CN108949800B (en) | A kind of efficient convenient gene location is inserted into Genetic Transformation System of Filamentous Fungi and its application at seat | |
CN1721541A (en) | Expression vector for secreting expression of exogenous gene in Escherichia coli or bacillus and its construction | |
CN110331170A (en) | The gene expression element and its construction method of a kind of dual gRNA and application | |
CN109777829A (en) | A kind of construction method of the sgRNA expression component of gene editing U6 promoter driving | |
CN114317529B (en) | Random splicing method of oligonucleotide chains | |
CN112760241B (en) | Recombinant penicillium chrysogenum gene engineering bacterium and construction method and application thereof | |
DK1694846T3 (en) | Cell with enhanced secretion mediated by MrgA protein or a homolog | |
CN107964562B (en) | Nucleic acid typing standard substance with fluorescent label and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100407 Termination date: 20141201 |
|
EXPY | Termination of patent right or utility model |